Literature DB >> 16131759

Structure of Ecballium elaterium trypsin inhibitor II (EETI-II): a rigid molecular scaffold.

Ralph Krätzner1, Judit E Debreczeni, Thomas Pape, Thomas R Schneider, Alexander Wentzel, Harald Kolmar, George M Sheldrick, Isabel Uson.   

Abstract

The Ecballium elaterium trypsin inhibitor II (EETI-II) belongs to the family of squash inhibitors and is one of the strongest inhibitors known for trypsin. The eight independent molecules of EETI-II in the crystal structure reported here provide a good opportunity to test the hypothesis that this small cystine-knot protein (knottin) is sufficiently rigid to be used as a molecular scaffold for protein-engineering purposes. To extend this test, the structures of two complexes of EETI-II with trypsin have also been determined, one carrying a four-amino-acid mutation of EETI-II. The remarkable similarity of these structures confirms the rigidity of the molecular framework and hence its suitability as a molecular scaffold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131759     DOI: 10.1107/S0907444905021207

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  15 in total

1.  Heterochiral Knottin Protein: Folding and Solution Structure.

Authors:  Surin K Mong; Frank V Cochran; Hongtao Yu; Zachary Graziano; Yu-Shan Lin; Jennifer R Cochran; Bradley L Pentelute
Journal:  Biochemistry       Date:  2017-10-17       Impact factor: 3.162

Review 2.  Advances, interactions, and future developments in the CNS, Phenix, and Rosetta structural biology software systems.

Authors:  Paul D Adams; David Baker; Axel T Brunger; Rhiju Das; Frank DiMaio; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

3.  Challenging the state of the art in protein structure prediction: Highlights of experimental target structures for the 10th Critical Assessment of Techniques for Protein Structure Prediction Experiment CASP10.

Authors:  Andriy Kryshtafovych; John Moult; Patrick Bales; J Fernando Bazan; Marco Biasini; Alex Burgin; Chen Chen; Frank V Cochran; Timothy K Craig; Rhiju Das; Deborah Fass; Carmela Garcia-Doval; Osnat Herzberg; Donald Lorimer; Hartmut Luecke; Xiaolei Ma; Daniel C Nelson; Mark J van Raaij; Forest Rohwer; Anca Segall; Victor Seguritan; Kornelius Zeth; Torsten Schwede
Journal:  Proteins       Date:  2014-02

4.  Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I.

Authors:  Jeffrey Austin; Wan Wang; Swamy Puttamadappa; Alexander Shekhtman; Julio A Camarero
Journal:  Chembiochem       Date:  2009-11-02       Impact factor: 3.164

5.  Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.

Authors:  Richard H Kimura; Aron M Levin; Frank V Cochran; Jennifer R Cochran
Journal:  Proteins       Date:  2009-11-01

6.  Asteropsins B-D, sponge-derived knottins with potential utility as a novel scaffold for oral peptide drugs.

Authors:  Huayue Li; John J Bowling; Mingzhi Su; Jongki Hong; Bong-Jin Lee; Mark T Hamann; Jee H Jung
Journal:  Biochim Biophys Acta       Date:  2013-11-10

Review 7.  Peptide-based protease inhibitors from plants.

Authors:  Roland Hellinger; Christian W Gruber
Journal:  Drug Discov Today       Date:  2019-06-03       Impact factor: 7.851

8.  Four small puzzles that Rosetta doesn't solve.

Authors:  Rhiju Das
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

9.  Knottin cyclization: impact on structure and dynamics.

Authors:  Annie Heitz; Olga Avrutina; Dung Le-Nguyen; Ulf Diederichsen; Jean-François Hernandez; Jérôme Gracy; Harald Kolmar; Laurent Chiche
Journal:  BMC Struct Biol       Date:  2008-12-12

10.  Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein.

Authors:  Jennifer L Lahti; Adam P Silverman; Jennifer R Cochran
Journal:  PLoS Comput Biol       Date:  2009-09-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.